Neupro can treat Parkinson's disease and Restless Legs Syndrome

Share this article:
Neupro can treat Parkinson's disease and Restless Legs Syndrome
Neupro can treat Parkinson's disease and Restless Legs Syndrome

UCB has announced the launch of Neupro in the United States for the treatment of Parkinson's disease and restless legs syndrome. The once-daily patch provides continuous delivery of the dopamine agonist rotigotine. The Food & Drug Administration approved the medication in April. Parkinson's affects about one million Americans, while up to 23 million Americans may be afflicted by Restless Leg Syndrome.

Share this article:
close

Next Article in Products

More in Products

Aviv REIT offers public stock

Aviv REIT announced the public offering of 8 million shares of common stock at a public offering price of $24.10 per share.

NCAL unveils 2014 Assisted Living Week logo

NCAL unveils 2014 Assisted Living Week logo

The National Center for Assisted Living is encouraging communities to use the 2014 "The Magic of Music" logo to celebrate National Assisted Living Week.

New healthcare educational catalog available

New healthcare educational catalog available

Nasco has released its 2014-2015 Health Care Educational Materials catalog, which focuses on training with versatile medical procedure simulators.